Array
(
[id] => 1677
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1677.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:00
[updatetime] => 2024-12-12 11:19:00
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => Either an anticoagulant (Direct Oral Anticoagulant (DOAC), Low Molecular Weight Heparin (LMWH), or fondaparinux) for the entire duration of thromboprophylaxis .（Evidence level:High；Recommendation grade:Strong）
[laiyuan] => 在整个血栓预防期间使用一种抗凝剂（直接口服抗凝剂、低分子量肝素或磺达肝癸钠）。（证据分级：高；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973540
[_updatetime] => 1733973540
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在整个血栓预防期间使用一种抗凝剂（直接口服抗凝剂、低分子量肝素或磺达肝癸钠）。（证据分级：高；推荐强度：强推荐）
Either an anticoagulant (Direct Oral Anticoagulant (DOAC), Low Molecular Weight Heparin (LMWH), or fondaparinux) for the entire duration of thromboprophylaxis .（Evidence level:High；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1678
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2025 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1678.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:00
[updatetime] => 2024-12-12 11:19:00
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => Sequential thromboprophylaxis, starting with 5 days of anticoagulant followed by aspirin for 30 days after THA or 9 days after TKA, if the patient is successfully managed in an Enhanced Recovery After Surgery (ERAS) pathway and does not have any major risk factors for VTE** or multiple minor risk factors. （Evidence level:High；Recommendation grade:Strong）
[laiyuan] => 进行序贯性血栓预防，在全髋关节置换术后先使用抗凝剂5天，然后使用阿司匹林30天，或者在全膝关节置换术后先使用抗凝剂5天，然后使用阿司匹林9天。前提是患者在术后加速康复路径中得到成功管理，并且没有静脉血栓栓塞的任何主要危险因素或多种次要危险因素。（证据分级：高；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973540
[_updatetime] => 1733973540
[_nrjc] =>
[_nrsh] =>
)
推荐意见
进行序贯性血栓预防，在全髋关节置换术后先使用抗凝剂5天，然后使用阿司匹林30天，或者在全膝关节置换术后先使用抗凝剂5天，然后使用阿司匹林9天。前提是患者在术后加速康复路径中得到成功管理，并且没有静脉血栓栓塞的任何主要危险因素或多种次要危险因素。（证据分级：高；推荐强度：强推荐）
Sequential thromboprophylaxis, starting with 5 days of anticoagulant followed by aspirin for 30 days after THA or 9 days after TKA, if the patient is successfully managed in an Enhanced Recovery After Surgery (ERAS) pathway and does not have any major risk factors for VTE** or multiple minor risk factors. （Evidence level:High；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1679
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1679.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:00
[updatetime] => 2024-12-12 11:19:00
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend the use of LMWH or fondaparinux for 4 weeks after hip fracture surgery.（Evidence level:High；Recommendation grade:Strong）
[laiyuan] => 我们建议在髋部骨折手术后使用低分子量肝素或磺达肝癸钠，持续4周。（证据分级：高；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973540
[_updatetime] => 1733973540
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议在髋部骨折手术后使用低分子量肝素或磺达肝癸钠，持续4周。（证据分级：高；推荐强度：强推荐）
We recommend the use of LMWH or fondaparinux for 4 weeks after hip fracture surgery.（Evidence level:High；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1680
[catid] => 291
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1680.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:00
[updatetime] => 2024-12-12 11:19:00
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => If surgery is delayed, we suggest starting thromboprophylaxis preoperatively, preferably with LMWH, with a minimal interval of 12 hours between the last LMWH injection and surgery.（Evidence level:moderate/Low；Recommendation grade:Strong）
[laiyuan] => 如果手术推迟，我们建议在术前就开始进行血栓预防，最好使用低分子量肝素，且在上次注射低分子量肝素与手术之间至少间隔12小时。（证据分级：中或低；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973540
[_updatetime] => 1733973540
[_nrjc] =>
[_nrsh] =>
)
推荐意见
如果手术推迟，我们建议在术前就开始进行血栓预防，最好使用低分子量肝素，且在上次注射低分子量肝素与手术之间至少间隔12小时。（证据分级：中或低；推荐强度：强推荐）
If surgery is delayed, we suggest starting thromboprophylaxis preoperatively, preferably with LMWH, with a minimal interval of 12 hours between the last LMWH injection and surgery.（Evidence level:moderate/Low；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1681
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1681.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:00
[updatetime] => 2024-12-12 11:19:00
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest continuing thromboprophylaxis until ambulation with full weight-bearing is achieved and for a minimum duration of 7 days. （Evidence level:moderate/Low；Recommendation grade:Strong）
[laiyuan] => 我们建议持续进行血栓预防，直至能够完全负重行走，且至少持续7天。（证据分级：中或低；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973540
[_updatetime] => 1733973540
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议持续进行血栓预防，直至能够完全负重行走，且至少持续7天。（证据分级：中或低；推荐强度：强推荐）
We suggest continuing thromboprophylaxis until ambulation with full weight-bearing is achieved and for a minimum duration of 7 days. （Evidence level:moderate/Low；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1682
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1682.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:00
[updatetime] => 2024-12-12 11:19:00
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We do not recommend aspirin for venous thromboprophylaxis. （Evidence level:High；Recommendation grade:weak）
[laiyuan] => 我们不推荐使用阿司匹林进行静脉血栓预防。（证据分级：高；推荐强度：弱推荐）
[znzldj] => B级
[_inputtime] => 1733973540
[_updatetime] => 1733973540
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们不推荐使用阿司匹林进行静脉血栓预防。（证据分级：高；推荐强度：弱推荐）
We do not recommend aspirin for venous thromboprophylaxis. （Evidence level:High；Recommendation grade:weak）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1683
[catid] => 302
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1683.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:00
[updatetime] => 2024-12-12 11:19:00
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest against routine pharmacological thromboprophylaxis after knee ligament repair, simple arthroscopy, meniscectomy, forefoot surgery, or removal of osteosynthesis material.（Evidence level:moderate/Low；Recommendation grade:weak）
[laiyuan] => 我们建议在膝关节韧带修复、单纯关节镜检查、半月板切除术、前足手术或者内固定材料取出术后，不要常规进行药物性血栓预防。（证据分级：中或低；推荐强度：弱推荐）
[znzldj] => B级
[_inputtime] => 1733973540
[_updatetime] => 1733973540
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议在膝关节韧带修复、单纯关节镜检查、半月板切除术、前足手术或者内固定材料取出术后，不要常规进行药物性血栓预防。（证据分级：中或低；推荐强度：弱推荐）
We suggest against routine pharmacological thromboprophylaxis after knee ligament repair, simple arthroscopy, meniscectomy, forefoot surgery, or removal of osteosynthesis material.（Evidence level:moderate/Low；Recommendation grade:weak）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1684
[catid] => 291
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1684.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:00
[updatetime] => 2024-12-12 11:19:00
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => If the patient has a major personal VTE risk factor** or several minor risk factors, we suggest thromboprophylaxis with an anticoagulant (anti-Xa DOAC or LMWH) .（Evidence level:moderate/Low；Recommendation grade:Strong）
[laiyuan] => 如果患者存在静脉血栓栓塞的主要个人危险因素或者若干次要危险因素，我们建议使用一种抗凝剂（抗 Xa 直接口服抗凝剂或低分子量肝素）进行血栓预防。（证据分级：中或低；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973540
[_updatetime] => 1733973540
[_nrjc] =>
[_nrsh] =>
)
推荐意见
如果患者存在静脉血栓栓塞的主要个人危险因素或者若干次要危险因素，我们建议使用一种抗凝剂（抗 Xa 直接口服抗凝剂或低分子量肝素）进行血栓预防。（证据分级：中或低；推荐强度：强推荐）
If the patient has a major personal VTE risk factor** or several minor risk factors, we suggest thromboprophylaxis with an anticoagulant (anti-Xa DOAC or LMWH) .（Evidence level:moderate/Low；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1685
[catid] => 291
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1685.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:00
[updatetime] => 2024-12-12 11:19:00
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend thromboprophylaxis with LMWH for 4 weeks, including minimally invasive surgery or ERAS pathway.（Evidence level:High；Recommendation grade:Strong）
[laiyuan] => 我们推荐使用低分子量肝素进行为期4周的血栓预防，包括在微创手术或实施加速康复外科路径的情况。（证据分级：高；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973540
[_updatetime] => 1733973540
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们推荐使用低分子量肝素进行为期4周的血栓预防，包括在微创手术或实施加速康复外科路径的情况。（证据分级：高；推荐强度：强推荐）
We recommend thromboprophylaxis with LMWH for 4 weeks, including minimally invasive surgery or ERAS pathway.（Evidence level:High；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
Array
(
[id] => 1686
[catid] => 291
[title] => Prevention of perioperative venous thromboembolism: 2024 guidelines from the French Working Group on Perioperative Haemostasis (GIHP) developed in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Society of Vascular Medicine (SFMV) and endorsed by the French Society of Digestive Surgery (SFCD), the French Society of Pharmacology and Therapeutics (SFPT) and INNOVTE (Investigation Network On Venous ThromboEmbolism) network
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 3
[author] => 甘肃中医院
[status] => 9
[url] => https://www.anes-guide.com/show/1686.html
[link_id] => 0
[tableid] => 0
[inputip] => 39.144.210.1
[inputtime] => 2024-12-12 11:19:00
[updatetime] => 2024-12-12 11:19:00
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/39447869/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2024
[guojia] => Anaesthesia, critical care & pain medicine
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that fondaparinux may be used as an alternative to LMWH.（Evidence level:moderate/Low；Recommendation grade:Strong）
[laiyuan] => 我们建议磺达肝癸钠可以作为低分子量肝素的一种替代药物来使用。（证据分级：中或低；推荐强度：强推荐）
[znzldj] => B级
[_inputtime] => 1733973540
[_updatetime] => 1733973540
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议磺达肝癸钠可以作为低分子量肝素的一种替代药物来使用。（证据分级：中或低；推荐强度：强推荐）
We suggest that fondaparinux may be used as an alternative to LMWH.（Evidence level:moderate/Low；Recommendation grade:Strong）
证据评价方法：GRADE
指南质量等级：B级
年份：2024
国家：Anaesthesia, critical care & pain medicine
